Mark J. Vignola

Insider Reports History

Entity
Individual
Location
C/O Applied Therapeutics, Inc., 340 Madison Avenue, 19 Th Floor, New York, NY
Signature
/s/ David Strauss, as Attorney-in-Fact for Mark J. Vignola
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark J. Vignola:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Terns Pharmaceuticals, Inc. Chief Financial Officer Common Stock 91.9K $1.01M $11.00 Sep 10, 2024 Direct
Terns Pharmaceuticals, Inc. Chief Financial Officer Stock Option (Right to Buy) 55K Sep 10, 2024 Direct

Insider Reports Filed by Mark J. Vignola

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TERN Terns Pharmaceuticals, Inc. Sep 10, 2024 3 -$56.4K 4 Sep 12, 2024 Chief Financial Officer
TERN Terns Pharmaceuticals, Inc. May 31, 2024 1 $21.3K 4 Jun 4, 2024 Chief Financial Officer
TERN Terns Pharmaceuticals, Inc. Jan 23, 2024 2 $0 4 Jan 25, 2024 Chief Financial Officer
TERN Terns Pharmaceuticals, Inc. Nov 30, 2023 1 $2.81K 4 Dec 4, 2023 Chief Financial Officer
TERN Terns Pharmaceuticals, Inc. May 31, 2023 1 $14.1K 4 Jun 2, 2023 Chief Financial Officer
TERN Terns Pharmaceuticals, Inc. Feb 1, 2023 2 $4.23 4 Feb 3, 2023 Chief Financial Officer
TERN Terns Pharmaceuticals, Inc. May 31, 2022 1 $11.3K 4 Jun 8, 2022 Chief Financial Officer
TERN Terns Pharmaceuticals, Inc. Jan 26, 2022 1 $0 4 Jan 28, 2022 Chief Financial Officer
TERN Terns Pharmaceuticals, Inc. Sep 28, 2021 1 $0 4 Sep 30, 2021 Chief Financial Officer